Key statistics
On Friday, Crinetics Pharmaceuticals Inc (CRNX:NSQ) closed at 31.93, 32.49% above the 52 week low of 24.10 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.61 |
---|---|
High | 32.21 |
Low | 31.35 |
Bid | 30.10 |
Offer | 33.19 |
Previous close | 31.99 |
Average volume | 932.18k |
---|---|
Shares outstanding | 93.68m |
Free float | 90.35m |
P/E (TTM) | -- |
Market cap | 2.99bn USD |
EPS (TTM) | -3.82 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
- Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025
- Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
- Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
- Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
- Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
- Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
- Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
- Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼